VITRO DIAGNOSTICS INC
10QSB, EX-27, 2000-09-21
BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Previous: VITRO DIAGNOSTICS INC, 10QSB, 2000-09-21
Next: ASIA PACIFIC FUND INC, POS AMI, 2000-09-21



<TABLE> <S> <C>


<ARTICLE>                     5
<LEGEND>
This  schedule  contains  summary  financial   information  extracted  from  the
Financial  Statements  of the  Company  at July  31,  2000  (Unaudited)  and the
Statement of Income for the Nine Months Ended July 31, 2000  (Unaudited).  It is
qualified in its entirety by reference to such financial statements.
</LEGEND>

<S>                                       <C>
<PERIOD-TYPE>                               9-MOS
<FISCAL-YEAR-END>                                       Oct-31-2000
<PERIOD-END>                                            Jul-31-2000
<CASH>                                                      250,000
<SECURITIES>                                                      0
<RECEIVABLES>                                               450,000
<ALLOWANCES>                                                      0
<INVENTORY>                                                       0
<CURRENT-ASSETS>                                            700,000
<PP&E>                                                            0
<DEPRECIATION>                                                    0
<TOTAL-ASSETS>                                              844,539
<CURRENT-LIABILITIES>                                             0
<BONDS>                                                           0
<COMMON>                                                    283,036
                                             0
                                                       0
<OTHER-SE>                                                  561,503
<TOTAL-LIABILITY-AND-EQUITY>                                844,539
<SALES>                                                           0
<TOTAL-REVENUES>                                                  0
<CGS>                                                             0
<TOTAL-COSTS>                                                     0
<OTHER-EXPENSES>                                            589,077
<LOSS-PROVISION>                                                  0
<INTEREST-EXPENSE>                                           20,894
<INCOME-PRETAX>                                            (256,214)
<INCOME-TAX>                                                      0
<INCOME-CONTINUING>                                        (256,214)
<DISCONTINUED>                                              652,149
<EXTRAORDINARY>                                                   0
<CHANGES>                                                         0
<NET-INCOME>                                                 74,072
<EPS-BASIC>                                                  0.01
<EPS-DILUTED>                                                  0.01




</TABLE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission